Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Evaluation of Autonomic, Imaging and Genetic Markers for Parkinson-related Dementia : Longitudinal Assessment of a PD Cohort.

Trial N/A Completed Dec. 4, 2023

Early Biomarkers of Neurodegeneration in Parkinsonian Syndromes

Trial N/A Not yet recruiting Dec. 4, 2023

The Role of EEG in Identifying Cognitive Changes in Parkinson's Disease

Trial N/A Unknown Nov. 30, 2023

Randomized Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells (PASCs)

Trial Phase 1 Unknown Nov. 30, 2023

PD Frontline (Part of RAPSODI GD) Remote Assessment of People With Parkinson's

Trial N/A Recruiting Nov. 29, 2023

RBD Longitudinal as Prognostic for PD

Trial N/A Unknown Nov. 28, 2023

A Study to Evaluate SAGE-217 in Participants With Parkinson's Disease

Trial Phase 2 Completed Nov. 28, 2023

Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease

Trial Phase 1 Completed Nov. 28, 2023

Comparison of Dopamin Level in Idiopathic Parkinson's Patients

Trial Phase 4 Unknown Nov. 27, 2023

A Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD)

Trial Phase 3 Completed Nov. 27, 2023

Evaluation of the Nonmotor Symptomatology of Parkinsonian Patients Treated With Two Strategies Related to Apomorphine Pump Therapy in French Hospitals

Trial N/A Completed Nov. 26, 2023

Digital Wearable Walking Aid for Freezing of Gait in Parkinson´s Disease

Trial N/A Completed Nov. 26, 2023

The Relationship Between Trunk Control and Hand Functions in Individuals With Parkinson's

Trial N/A Unknown Nov. 23, 2023

A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery

Trial N/A Completed Nov. 21, 2023

An Observational Study of Parkinson's Disease and Other Synucleinopathies (EASE-PD)

Trial N/A Completed Nov. 21, 2023

Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

Trial Phase 3 Completed Nov. 21, 2023

Assessment of Pupil Light Responses in Patients With Parkinson Disease

Trial N/A Unknown Nov. 21, 2023

Cost-effectiveness of Nursing Interventions for Patients With PD

Trial N/A Completed Nov. 21, 2023

Exercise in Advanced Parkinson's Disease (PD) With Deep Brain Stimulation (DBS)

Trial N/A Completed Nov. 20, 2023

Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia

Trial Phase 2 Suspended Nov. 17, 2023